Las retiradas de medicamentos por parte de la FDA son legalmente complejas, lo que dificulta la eliminación de tratamientos aprobados incluso cuando surgen preocupaciones sobre la seguridad o la eficacia.
Resumen generado con IA. Consulta el original para comprobar el contexto y la precisión.
Este es el extracto disponible del feed. Puede estar abreviado o en el idioma original.
In May 2021, the US Food and Drug Administration released a lengthy briefing document on an experimental medication for a rare autoimmune form of vasculitis that often damages the kidneys and lungs. The agency was on the fence about whether to approve the treatment, and it wanted an independent advisory committee to weigh in. Among the questions at hand: Was the drug meaningfully better than existing therapies? Participants in the study, which had been conducted by the California biotechnology company ChemoCentryx, did appear to have slightly higher rates of symptom remission after one year. But according to the FDA, it was hard to interpret the results because the study’s design had been less than optimal. Some advisory committee members expressed a similar view. The effect of the drug, said one, “is just not well verified by this study.” At the same time, many patients, and some physicians, saw in the data a potentially helpful medication, one that might lessen patients’ reliance on steroids, which are highly effective but often cause severe side effects.Read full article Comments
Una ayuda automática para ordenar, basada en fuentes, palabras clave y entidades, en una escala de 1–12. Alta: 9–12; media: 6–8; baja: 1–5. No mide urgencia, verifica noticias ni representa respaldo editorial.
Best Buy ofrece una tarjeta de regalo de 100 dólares con los nuevos pedidos anticipados de MacBook Pro con pantalla táctil, brindando un incentivo financiero inmediato a los clientes que eligen su tienda frente a la competencia.
La dependencia de Vic Mensa de la app Voice Memos destaca su proceso creativo, pero el texto truncado del artículo impide una evaluación completa de su importancia más amplia.
El malware impulsado por IA ahora automatiza el robo de datos sensibles, como credenciales e información financiera, aumentando significativamente la escala y la eficiencia del cibercrimen.